SCHEMBL17872128

SCHEMBL17872128

CC1(C)c2c(c(Nc3cccc(N)c3)nn2C(=O)O)CN1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
GFER P55789 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 1/20 0.36
PIM1 P11309 1/20 0.36
CREBBP Q92793 10/20 0.35
BRD4 O60885 9/20 0.35
EP300 Q09472 7/20 0.35
DDX3X O00571 1/20 0.35
PIK3CA P42336 1/20 0.35
PRKDC P78527 1/20 0.35
MAPK1 P28482 1/20 0.34
MAPK13 O15264 2/20 0.34
MAPK12 P53778 2/20 0.34
MAPK11 Q15759 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17872100 0.75 CDK7 (0.52) MAPK1SRC
SCHEMBL20741173 0.72 CDK7 (0.61) MAPK1SRC
SCHEMBL17872104 0.72 CDK7 (0.61) MAPK1SRC
SCHEMBL23260770 0.70 C5AR1 (0.36) CREBBPBRD4EP300
SCHEMBL19305457 0.63
Acetic Acid SCHEMBL5914600 0.62 MAPT (0.78) KDM4EMEN1LMNAGAAMAPT
SCHEMBL4167089 0.61 MAPT (0.49) KDM4EMEN1LMNAGAAMAPT
SCHEMBL2127990 0.59 MAPT (0.86) KDM4EMEN1LMNAGAAMAPT
SCHEMBL1415666 0.58 ALDH1A1 (0.60) KDM4EMEN1LMNAGAAMAPT
SCHEMBL6324644 0.58 DHODH (0.72) MEN1LMNAGAAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3236959-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) Dana Farber Cancer Institute, Inc. (US) 2017-11-01 EP disclosed
WO-2016105528-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) DANA-FARBER CANCER INSTITUTE, INC. (US) 2016-06-30 WO disclosed